ConcertAIConcertAI is the leader in Predictive and Generative AI SaaS and Real-world Data research solutions and healthcare and life sciences. Our mission is to accelerate insights and outcomes for patients through research-ready data, CARA™ AI technologies, and scientific expertise in partnership with over 46 leading biomedical innovators, 2,000 health care providers, and medical societies. CancerLinQ® is an Initiative of ConcertAI, providing oncology providers with automated versions of ASCO-defined quality solutions such as QOPI and ASCO CertifiedTM. Headquartered in Cambridge, MA, ConcertAI has offices in Bangalore, Frankfurt, Philadelphia, Raleigh-Durham, and Tokyo. For more information, visit us at www.concertai.com.
